Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daum

Showing results (161-170 of 337) with videos related to

Pageof 34
Sort By:
JAMA|March 4, 1992
Severe measles in immunocompromised patientsL J Kaplan, R S Daum, M Smaron, et al.
JAMA|July 3, 1996
The effect of epidemic measles on immunization ratesK P Goldstein, T J Philipson, H Joo, et al.
Pediatrics|April 1, 1982
Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infectionR S Daum, G R Siber, J S Kamon, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factorsA H Suggs, M C Maranan, S Boyle-Vavra, et al.
Pediatrics|November 1, 1996
Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimenK M Bewley, J G Schwab, G A Ballanco, et al.
Praxis Und Klinik Der Pneumologie|November 1, 1980
[Isolated sarcoidosis of the upper mediastinal lymph nodes (author's transl)]G Parzinger, A Harlacher, G H von Donnersmarck, et al.
The Journal of Infectious Diseases|August 27, 2002
Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolatesFarid M Hussain, Susan Boyle-Vavra, Priya B Shete, et al.
Pediatrics|December 5, 2003
Obstacles to the elimination of Haemophilus influenzae type b disease: three illustrative casesMichael J Donnelly, Betsy C Herold, Steven G Jenkins, et al.
Pediatrics|December 3, 2004
On-time immunization rates among children who enter Chicago public schoolsSamuel R Dominguez, J Scott Parrott, Diane S Lauderdale, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesS Boyle-Vavra, S K Berke, J C Lee, et al.
Pageof 34

Showing results (161-170 of 337) with videos related to

Sort By:
Pageof 34
JAMA|March 4, 1992
Severe measles in immunocompromised patientsL J Kaplan, R S Daum, M Smaron, et al.
JAMA|July 3, 1996
The effect of epidemic measles on immunization ratesK P Goldstein, T J Philipson, H Joo, et al.
Pediatrics|April 1, 1982
Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infectionR S Daum, G R Siber, J S Kamon, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factorsA H Suggs, M C Maranan, S Boyle-Vavra, et al.
Pediatrics|November 1, 1996
Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimenK M Bewley, J G Schwab, G A Ballanco, et al.
Praxis Und Klinik Der Pneumologie|November 1, 1980
[Isolated sarcoidosis of the upper mediastinal lymph nodes (author's transl)]G Parzinger, A Harlacher, G H von Donnersmarck, et al.
The Journal of Infectious Diseases|August 27, 2002
Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolatesFarid M Hussain, Susan Boyle-Vavra, Priya B Shete, et al.
Pediatrics|December 5, 2003
Obstacles to the elimination of Haemophilus influenzae type b disease: three illustrative casesMichael J Donnelly, Betsy C Herold, Steven G Jenkins, et al.
Pediatrics|December 3, 2004
On-time immunization rates among children who enter Chicago public schoolsSamuel R Dominguez, J Scott Parrott, Diane S Lauderdale, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesS Boyle-Vavra, S K Berke, J C Lee, et al.
Pageof 34